Report Categories Report Categories

Report Categories

industry Category

All

Total: 2 records, 1 pages

Global Non-Invasive Cancer Detection Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 01 Oct 2024

date Service & Software

new_biaoQian Non-Invasive Cancer Detection

Non-invasive cancer testing is a technology that detects cancer by analyzing biomarkers in body fluids such as blood, urine, and saliva without surgery or tissue biopsy. Common non-invasive testing methods include liquid biopsy, genetic testing, and imaging technology, which can detect cancer-related DNA, RNA, proteins, or circulating tumor cells (CTCs) to detect cancer early or monitor disease progression. Non-invasive testing is more comfortable for patients and has lower risks, and is particularly suitable for cancer screening, treatment effect evaluation, and recurrence monitoring.

USD3480.00

Add To Cart

Add To Cart

Global Non-Invasive Cancer Detection Supply, Demand and Key Producers, 2024-2030

date 01 Oct 2024

date Service & Software

new_biaoQian Non-Invasive Cancer Detection

Non-invasive cancer testing is a technology that detects cancer by analyzing biomarkers in body fluids such as blood, urine, and saliva without surgery or tissue biopsy. Common non-invasive testing methods include liquid biopsy, genetic testing, and imaging technology, which can detect cancer-related DNA, RNA, proteins, or circulating tumor cells (CTCs) to detect cancer early or monitor disease progression. Non-invasive testing is more comfortable for patients and has lower risks, and is particularly suitable for cancer screening, treatment effect evaluation, and recurrence monitoring.

USD4480.00

Add To Cart

Add To Cart

industry 01 Oct 2024

industry Service & Software

new_biaoQian Non-Invasive Cancer Detection

Non-invasive cancer testing is a technology that detects cancer by analyzing biomarkers in body fluids such as blood, urine, and saliva without surgery or tissue biopsy. Common non-invasive testing methods include liquid biopsy, genetic testing, and imaging technology, which can detect cancer-related DNA, RNA, proteins, or circulating tumor cells (CTCs) to detect cancer early or monitor disease progression. Non-invasive testing is more comfortable for patients and has lower risks, and is particularly suitable for cancer screening, treatment effect evaluation, and recurrence monitoring.

USD3480.00

addToCart

Add To Cart

industry 01 Oct 2024

industry Service & Software

new_biaoQian Non-Invasive Cancer Detection

Non-invasive cancer testing is a technology that detects cancer by analyzing biomarkers in body fluids such as blood, urine, and saliva without surgery or tissue biopsy. Common non-invasive testing methods include liquid biopsy, genetic testing, and imaging technology, which can detect cancer-related DNA, RNA, proteins, or circulating tumor cells (CTCs) to detect cancer early or monitor disease progression. Non-invasive testing is more comfortable for patients and has lower risks, and is particularly suitable for cancer screening, treatment effect evaluation, and recurrence monitoring.

USD4480.00

addToCart

Add To Cart